These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 953955)

  • 21. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 22. 1-(2-Chloroethyl)-cyclohexyl-nitrosourea-induced remission in essential thrombocythemia.
    Leoni F; Grossi A; Rossi Ferrini P
    Acta Haematol; 1983; 69(3):180-3. PubMed ID: 6404101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).
    Sonntag RW; Brunner KW; Batz K; Ryssel HJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ; Nelson RA; Norgard MJ
    Oncology; 1975; 32(2):82-5. PubMed ID: 815858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 26. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

  • 27. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
    Young RC; Walker MD; Canellos GP; Schein PS; Chabner BA; DeVita VT
    Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
    [No Abstract]   [Full Text] [Related]  

  • 29. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
    Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
    J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors.
    Fewer D; Wilson CB; Boldrey EB; Enot JK
    Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE; White M; Ware DE; Robinson WA
    Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
    Heading KL; Brockley LK; Bennett PF
    Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO; Lavin PT; Moertel CG
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail.
    Pouillart P; Mathe G; Thy TH; Lheritier J; Poisson M; Huguenin P; Gauthier H; Morin P; Parrot R
    Cancer; 1976 Nov; 38(5):1909-16. PubMed ID: 1033028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
    Chang P; Levine MA; Wiernik PH; Walker MD
    Cancer; 1976 Feb; 37(2):615-9. PubMed ID: 766946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some preliminary observations on chemotherapy of infantile medulloblastomas with vincristine sulfate and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)].
    Pompili A; Cianfriglia F; Occhipinti E
    Minerva Pediatr; 1978 Nov; 30(21):1721-4. PubMed ID: 723818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.